Lilly will provide an initial payment to complete a Phase I trial of OLX75016, which started in February 2024.

Scientists have discovered that some tiny segments of RNA thought to be junk instead have a functional role in suppressing ...

New research challenges previous assumptions about RNA transport, finding that RNA can carry instructions across generations.

Akribion Therapeutics emerges from stealth with €8 million in seed funding to develop a novel cancer RNA-guided approach ...

Jones Trading initiated coverage on ProQR Therapeutics N.V. (NASDAQ:PRQR) with a Buy rating and set a price target of $11.00, representing significant upside from the current price of $2.19. The ...

UMD researchers have discovered key mechanisms in gene regulation that could improve the design of RNA-based medicines.

Synthetic biologists from Yale were able to re-write the genetic code of an organism - a novel genomically recoded organism (GRO) with one stop codon - using a cellular platform that they developed ...

Akribion Therapeutics ("Akribion"), the early-stage biotech developing a unique, RNA-guided, nuclease-based technology for programmable cell depletion, today announces its exit from stealth and the ...

Mirvie, a pioneer in bringing a personalized, predictive, and preventive approach to serious pregnancy complications, today announced at the Society for Maternal-Fetal Medicine annual meeting that the ...

"This allows ribosomes to endure short collisions on problematic RNA sections, thereby promoting continuous protein production", Madern explains. The new technology gives researchers the ability ...